Wird geladen...
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Accumulating evidence suggests that a dysregulation of the glutamatergic system exists in the brains of schizophrenia patients. The metabotropic glutamate (mGlu) receptors are being investigated as novel drug targets for this disease, and have shown promise in both preclinical and clinical studies....
Gespeichert in:
| Veröffentlicht in: | Curr Opin Pharmacol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949078/ https://ncbi.nlm.nih.gov/pubmed/29486374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.02.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|